Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Co-treatment With Aromatase Inhibitor or Progestin on Endometrial abv3-integrin Expressions in Women With Recurrent Implantation Failure

NCT05437471 is registered in ClinicalTrials.gov with Universiti Kebangsaan Malaysia Medical Centre as lead sponsor.

NCT NCT05437471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05437471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Co-treatment With Aromatase Inhibitor or Progestin on Endometrial abv3-integrin Expressions in Women With Recurrent Implantation Failure
Lead sponsor
Universiti Kebangsaan Malaysia Medical Centre
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2020
Completion date
May 30, 2022
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

miscarriage, recurrent